NASDAQ:PPBT

Purple Biotech Slides Pre-Market With Cash Concerns in Focus
·

Purple Biotech Slides Pre-Market With Cash Concerns in Focus

Purple Biotech’s U.S.-listed shares closed at $2.81, down 16 cents, trailing sector gains as biotech indexes rose over 1%. The company filed a $200 million shelf registration but is limited to raising about $824,000 per year due to its market cap. Cash stood at $6.4 million at March’s end, expected to last through 2027. Its lead CAPTN-3 program remains preclinical, with no human efficacy data reported.
May 29, 2026

Stock Market Today

  • Why AI Infrastructure Stocks Are Emerging as Market Favorites
    May 29, 2026, 4:57 AM EDT. AI infrastructure stocks are gaining traction as key players in the expanding artificial intelligence sector. Investors are increasingly drawn to companies specializing in the hardware and software that support AI technologies, driven by growing demand across industries. These stocks are becoming market favorites due to their role in enabling AI applications, from data centers to cloud computing. Market watchers highlight the potential for strong returns as AI adoption accelerates globally. Despite the sector's promise, experts advise cautious investment and emphasize the importance of professional financial guidance given the volatile nature of tech stocks.